# OnCo record neuregen-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/neuregen-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "neuregen-therapeutics" ;
  schema:name "Neuregen Therapeutics"@en ;
  schema:alternateName "Neuregen Therapeutics Co., Ltd."@en, "纽伦捷生物医药科技（武汉）有限公司"@en ;
  schema:description "Neuregen Therapeutics is testing an injection for high-grade brain tumours that combines a cancer-killing virus, an immune booster and a technique meant to turn leftover tumour cells into cells that no longer divide."@en ;
  schema:url <https://onco.cc/companies/neuregen-therapeutics/>, <https://www.nrg-therapeutics.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.nrg-therapeutics.com/>, <https://www.nrg-therapeutics.com/company_profile.html>, <https://clinicaltrials.gov/study/NCT07710690> ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/oncolytic-virus/>, <https://onco.cc/technologies/cytokine-therapy/> .